[1]CurrentPatentAssignee:MITSUBISHICHEMICALHOLDINGSCORPORATION-EP1195372,2002,A1Locationinpatent:Page53
[2]CurrentPatentAssignee:MITSUBISHICHEMICALHOLDINGSCORPORATION;SENJUPHARMACEUTICALCO.,LTD.-EP1378247,2016,B1Locationinpatent:Paragraph0076
[1]CurrentPatentAssignee:MITSUBISHICHEMICALHOLDINGSCORPORATION-US5958944,1999,A
[2]CurrentPatentAssignee:MITSUBISHICHEMICALHOLDINGSCORPORATION;SENJUPHARMACEUTICALCO.,LTD.-EP1378247,2016,B1
[1]CurrentPatentAssignee:MITSUBISHICHEMICALHOLDINGSCORPORATION;SENJUPHARMACEUTICALCO.,LTD.-EP1378247,2016,B1
[1]CurrentPatentAssignee:MITSUBISHICHEMICALHOLDINGSCORPORATION;SENJUPHARMACEUTICALCO.,LTD.-EP1378247,2016,B1
[1]CurrentPatentAssignee:MITSUBISHICHEMICALHOLDINGSCORPORATION;SENJUPHARMACEUTICALCO.,LTD.-EP1378247,2016,B1
Title: Hideki Tokushige, et al. Effects of Topical Administration of Y-39983, a Selective Rho-Associated Protein Kinase Inhibitor, on Ocular Tissues in Rabbits and Monkeys Invest. Ophthalmol. Vis. Sci. July 2007 vol. 48no. 7 3216-3222
Title: Tokushige H, et al. Effects of Y-39983, a selective Rho-associated protein kinase inhibitor, on blood flow in optic nerve head in rabbits and axonal regeneration of retinal ganglion cells in rats. Curr Eye Res. 2011 Oct;36(10):964-70.
Title: Watabe H, et al. Effects of Rho-associated protein kinase inhibitors Y-27632 and Y-39983 on isolated rabbit ciliary arteries.Jpn J Ophthalmol. 2011 Jul;55(4):411-7. Epub 2011 Jun 11.
